Sam Altman's Merge Labs raises $252 million for non-surgical brain-computer interfaces

habr.com (Russian)

Sam Altman's new startup, Merge Labs, is developing non-surgical brain-computer interfaces. The company secured $252 million in seed funding. Merge Labs uses ultrasound and special molecules to read brain activity without surgery, differing from Elon Musk's Neuralink. Investors include OpenAI and Gabe Newell. The technology aims for natural AI interaction, with potential for a decade-long development timeline. The neurotechnology market is estimated at $400 billion in the US.


With a significance score of 5.5, this news ranks in the top 0.6% of today's 30968 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: